Repligen (RGEN) Net Cash Flow Growth (1y) (2011 - 2026)
Repligen (RGEN) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.93 Bn | 121.71 Bn | 1.96 Bn | -9.88% |
| 2 | Becton Dickinson | 44.94 Bn | 44.13 Bn | 2.15 Bn | 131.47% |
| 3 | Alcon | 33.13 Bn | 31.47 Bn | 1.53 Bn | - |
| 4 | Medline | 32.87 Bn | 30.63 Bn | 1.84 Bn | -47.85% |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn | -40.20% |
| 6 | West Pharmaceutical Services | 23.28 Bn | 22.84 Bn | 329.20 Mn | -196.55% |
| 7 | Solventum | 14.11 Bn | 13.55 Bn | 1.10 Bn | -41.07% |
| 8 | Cooper Companies | 13.80 Bn | 13.66 Bn | 735.40 Mn | 102.38% |
| 9 | Align Technology | 12.06 Bn | 11.00 Bn | 736.59 Mn | 84.02% |
| 10 | Repligen | 7.42 Bn | 6.43 Bn | 108.28 Mn | 129.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 129.26% |
| Dec 31, 2025 | -657.53% |
| Sep 30, 2025 | 253.30% |
| Jun 30, 2025 | -63.34% |
| Mar 31, 2025 | -334.30% |
| Dec 31, 2024 | -118.96% |
| Sep 30, 2024 | -188.07% |
| Jun 30, 2024 | -67.93% |
| Mar 31, 2024 | 449.04% |
| Dec 31, 2023 | 313.21% |
| Sep 30, 2023 | 299.54% |
| Jun 30, 2023 | 425.78% |
| Mar 31, 2023 | 54.20% |
| Dec 31, 2022 | -380.48% |
| Sep 30, 2022 | 86.52% |
| Jun 30, 2022 | -17.25% |
| Mar 31, 2022 | -2,317.88% |
| Dec 31, 2021 | -107.99% |
| Sep 30, 2021 | -959.38% |
| Jun 30, 2021 | 29.42% |